Unlearn.AI leverages artificial intelligence to revolutionize clinical trials by creating digital twins of patients. These digital replicas predict individual health trajectories, allowing for more efficient and precise study designs.
By integrating digital twins, Unlearn.AI enables smaller, more powerful trials, reducing costs and accelerating the approval process.
The platform offers real-time insights into predicted outcomes for various participant subgroups, enhancing decision-making throughout the study.
Additionally, it assists in identifying sensitive clinical endpoints, optimizing study designs to improve sensitivity at both population and subpopulation levels. This innovative approach aims to minimize trial failures and expedite clinical development.
